xGen™ Respiratory Virus Amplicon Panel
A panel consisting of primers designed to cover >98% of the RSV A, RSV B, Influenza A H1N1, Influenza A H3N2, Influenza B, and SARS-CoV-2 genomes. These primers obtain high levels of genome coverage from as low as 10–100 viral copies. xGen Amplicon Technology uses overlapping primer sets to provide comprehensive coverage in a single-tube, 2.5-hour workflow.
Receive your quote directly from the manufacturer.
The xGen™ Respiratory Virus Amplicon Panel offers a streamlined (DNA-to-sequencer in 2.5 hours), single-tube NGS workflow for studying respiratory syncytial virus (RSV) subtypes A and B, influenza A (H1N1 and H3N2), influenza B, and SARS-CoV-2. This Predesigned xGen Amplicon Panel built with xGen Amplicon technology includes amplicon tiling and creation of super amplicons to ensure comprehensive genome coverage and provide resistance to future viral mutations that may fall on a priming site, thus enabling future identification of novel variants. Identify the unidentified by using IDT’s solution for achieving comprehensive coverage of respiratory virus genomes RSV A, RSV B, Influenza A H1N1, Influenza A H3N2, Influenza B, and SARS-CoV-2.
